MNRGX
Price
$45.97
Change
-$0.02 (-0.04%)
Updated
Sep 17 closing price
Net Assets
18.45M
VTSAX
Price
$158.29
Change
-$0.12 (-0.08%)
Updated
Sep 17 closing price
Net Assets
1.95T
Interact to see
Advertisement

MNRGX vs VTSAX

Header iconMNRGX vs VTSAX Comparison
Open Charts MNRGX vs VTSAXBanner chart's image
Manor Growth
Price$45.97
Change-$0.02 (-0.04%)
VolumeN/A
Net Assets18.45M
Vanguard Total Stock Mkt Idx Adm
Price$158.29
Change-$0.12 (-0.08%)
VolumeN/A
Net Assets1.95T
MNRGX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MNRGX vs. VTSAX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNRGX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.95T vs. MNRGX (18.5M). VTSAX pays higher dividends than MNRGX: VTSAX (1.16) vs MNRGX (0.00). MNRGX was incepted earlier than VTSAX: MNRGX (26 years) vs VTSAX (25 years). MNRGX (0.99) is less costly to investors than VTSAX (0.04). MNRGX is a more actively managed with annual turnover of: 12.05 vs. VTSAX (2.00). MNRGX has a lower initial minimum investment than VTSAX: MNRGX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 17.19 vs. MNRGX (13.81). VTSAX return over 5 years is better than : 93.19 vs. MNRGX (52.01).
MNRGXVTSAXMNRGX / VTSAX
Total Expense Ratio0.990.042,475%
Annual Report Gross Expense Ratio0.990.042,475%
Fund Existence26 years25 years-
Gain YTD9.65712.37578%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets18.5M1.95T0%
Annual Yield % from dividends0.001.16-
Returns for 1 year13.8117.1980%
Returns for 3 years43.5967.6764%
Returns for 5 years52.0193.1956%
Returns for 10 years134.34232.2158%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOFA0.28N/A
+0.28%
Family Office of America Inc.
AURX1.84N/A
N/A
Nuo Therapeutics, Inc.
AXXTF0.59N/A
N/A
Axiata Group BHD
SHLAF378.93N/A
N/A
Schindler Holding AG
SNBIF16.45N/A
N/A
Sanbio Co Ltd.